• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar

Kahn Swick & Foti

Kahn Swick & Foti represents investors in securities fraud class actions, as well as shareholders and consumers harmed by corporate wrongdoing.

  • About Us
    • About Our Firm
    • Institutional Investor Services
    • KSF in the Community
    • Careers at KSF
    • Contact Us
  • Attorneys
  • Practice Areas
    • Securities Class Action Litigation
    • Corporate Governance And Derivative Litigation
    • Consumer Protection Litigation
    • Shareholder Mergers and Acquisitions Class Action Litigation
  • Current Cases
  • KSF News
  • Asset Recovery Services
  • Contact KSF

Ninth Circuit Hands Lead Plaintiff a Major Win in Khoja v. Orexigen Therapeutics, Inc.

Home»News»Ninth Circuit Hands Lead Plaintiff a Major Win in Khoja v. Orexigen Therapeutics, Inc.

Khoja v. Orexigen Therapeutics, Inc. et al., No.16-56069 (9th Circuit). On August 13, 2018, the Ninth Circuit Court of Appeals handed lead plaintiff a major win when it overturned much of the lower court’s order dismissing all claims against Defendant Orexigen Therapeutics, Inc.  In a detailed 59-page opinion written by Judge A. Wallace Tashima and designated for publication, the Court found that the trial court, “in dismissing the action” had “abused its discretion by improperly considering materials outside of the complaint.” Noting a “concerning pattern in securities cases like this one” -where defendants improperly “exploit[]”  the incorporation-by-reference doctrine and judicial notice procedure-the Court stated that this opinion aimed to “clarify” these procedures.

For a further analysis see,
Ninth Circuit Decries Consideration of Extraneous Matter, Reverses Securities Suit Dismissal
By Kevin LaCroix, THE D&O DIARY,  August 14, 2018

Click here to read the Orexigen Decision.

Filed Under: News

Previous Post: « Final Judgment Entered in $25 Million AAC Holdings Securities Class Action
Next Post: Sixth Circuit Court of Appeals Reverses Dismissal of Dougherty v. Esperion Therapeutics, Inc. »

Reader Interactions

Primary Sidebar

Current Cases

Maiden Holdings, Ltd. (NasdaqGS: MHLD)

Wirecard AG (OTC: WCAGY, WRCDF)

Whiting Petroleum Corporation (NYSE: WLL)

Oasis Petroleum Inc. (NYSE: OAS) Investigation

Parsley Energy, Inc. (NYSE: PE) Investigation

Pioneer Natural Resources Company (NYSE: PXD) Investigation

see more»
 

Join Our Mailing List

To receive news of interest to shareholders and consumers and learn about potential new cases, you may join our mailing list by entering your email below.

Terms and Conditions | Privacy Notice
X

© 2006-2019 Copyright. All rights reserved Kahn Swick & Foti LLC · Louisiana · New York — Kahn Swick & Foti LLP · California